“Mildronate” injections contribute to the inhibition of y-butyrobetaine hydroxylase, provoke a decrease in the level of free carnitine, and reduce carnitine-dependent oxidation in fatty acids. The drug improves metabolic processes, improves performance, reduces the manifestation of physical and mental stress. The tool also has a cardioprotective effect.
The drug "Mildronate" (intramuscularly) helps to regulate cellular immunity, eliminates disorders in the nervous system of a functional nature in people suffering from chronic alcoholism against the background of withdrawal syndrome. The medication is involved in the redistribution of blood flow to the ischemic zones, namely in the retina and brain.
The drug "Mildronate" (intramuscularly) is prescribed for reduced performance, physical stress, including athletes. The medication is recommended in the complex therapy of coronary heart disease (with angina pectoris, chronic insufficiency, heart attack and dishormonal cardiopathy), with withdrawal syndrome against the background of chronic alcoholism (in combination with specific therapy). The drug "Mildronate" (intramuscularly) is also used for disorders (chronic and acute) of cerebral blood supply, ie, in the treatment of cerebral strokes and chronic failure. In these cases, the drug is used as part of complex therapy.
The half-life of the drug is from three to six hours.
In chronic alcoholism, the drug "Mildronate" (intramuscularly) is recommended twice a day for half a gram, daily for seven or ten days.
For mental and physical overload, the medication is recommended for adult patients inside four times a day, 0.25 grams or intravenously 0.5 grams once a day. The duration of therapy is from ten to fourteen days. If necessary, a second course is recommended after two to three weeks. Athletes are prescribed inside twice a day before training 0.5-1 grams. During the preparatory period, the course lasts fourteen to twenty-one days, and during the competition ten to fourteen days.
With cerebrovascular insufficiency in the acute phase of cerebrovascular pathology, five milliliters of a ten percent solution is prescribed intravenously daily for ten days. Next, the medicine is prescribed orally by half a gram daily. The duration of therapy is two or three weeks.
The drug "Mildronate" (analogues of the drug, for example, the drug "Carnitine") is contraindicated in case of hypersensitivity and central nervous system lesions of an organic nature.
When using the drug, dyspeptic symptoms, itching, psychomotor agitation, tachycardia, changes in blood pressure are noted.
The safety of the drug during pregnancy has not been established. In this regard, the drug "Mildronate" (intramuscularly, intravenously and orally) is not prescribed. If necessary, use the drug during lactation, it is recommended to stop feeding.